Intas Pharma offers ORGOVYX for advanced hormone-sensitive prostate cancer treatment in Europe

Myovant Sciences and Accord Healthcare (owned by Ahmedabad-based ...

May 10, 2022 | Tuesday | News
Niramai, Healthians partner for breast cancer screening

On the occasion of Mother’s Day, Niramai has partnered with Heal...

May 9, 2022 | Monday | News
BDR Pharma launches gastric cancer drug FURMECIL

Mumbai-based BDR Pharmaceuticals has launched oral drug FURMECIL,...

April 20, 2022 | Wednesday | News
India approves US-based Navidea Biopharma's Lymphoaim for cancer detection

US-based Navidea Biopharmaceuticals has announced the regulatory appro...

April 19, 2022 | Tuesday | News
Global pharma companies announce Precision Cancer Consortium

The Precision Cancer Consortium (PCC) has announced the formation as a...

April 13, 2022 | Wednesday | News
Glenmark bags DCGI approval for Ph 1 trial of novel cancer molecule

Glenmark Pharmaceuticals has announced that its subsidiary Glenmark Sp...

April 11, 2022 | Monday | News
Apollo Cancer Centre opens in Bhubaneswar with advanced technologies

Chief Minister of Odisha, Naveen Patnaik inaugurated the Apollo Cancer...

April 2, 2022 | Saturday | News
Punjab launches PINK Project initiative for breast cancer treatment

Department of Health & Family Welfare, Government of Punjab, Roche...

April 1, 2022 | Friday | News
CURIA revolutionises cancer care globally

CURIA, developed by Innoplexus, has now become the most decentralised ...

March 31, 2022 | Thursday | News
Cancer Sheds Undruggability Tag

Undruggable cancer refers to those cancers with protein mutations whic...

March 31, 2022 | Thursday | Features
Pfizer launches 6th helpdesk in cancer hospitals in India

Pfizer has launched the Project Aastha helpdesk at the Regio...

March 10, 2022 | Thursday | News
Narayana Health City sets ACT centre in collaboration with Indian Cancer Society

Narayana Health City in association with the Indian Cancer Society has...

March 4, 2022 | Friday | News
BDR Pharma unveils prostate cancer drug BDENZA in 160 mg capacity

BDR Pharmaceuticals has launched BDENZA in 160 mg strength aiding the ...

February 28, 2022 | Monday | News
Addressing breast cancer burden with innovation and technology

In 2020 alone, 178,361 women were detected with breast cancer for the ...

March 1, 2022 | Tuesday | Views
Pfizer’s support to Tata Trusts Cancer Care prog helps screen close to 70,000 people for NCDs, cancer

Pfizer announced that its support to Tata Trusts Cancer Care programme...

February 21, 2022 | Monday | News
Datar Cancer Genetics bags FDA grant for prostate cancer detection blood test

Datar Cancer Genetics, with operations in the UK, Germany and India, h...

February 15, 2022 | Tuesday | News
MFine, Datar Genetics launch cancer screening prog on mobile

MFine in association with Datar Cancer Genetics has announced the laun...

February 14, 2022 | Monday | News
Roche inks MoU with Delhi State Cancer Institute

Roche Pharma India and Delhi State Cancer Institute (DSCI) have inked ...

February 12, 2022 | Saturday | News

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy